Distinct Protective Host Defenses against oral and vaginal Candidiasis

References

• Klein RS, Harris CA, Small CB, et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodefriency syndrome. N Engl J Med 1984; 311: 354–357.
   PubMed Web of Science ®Google Scholar
• Macher AM. The pathology of AIDS. Public Health Report 1988; 103: 246–254.
   PubMed Web of Science ®Google Scholar
• Clift RA. Candidiasis in the transplant patient. Amer J Med 1984; 77 (suppl 4D): 34–38.
   Google Scholar
• Knight L, Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticoster-iods and diabetes mellitus. J Infect Dis 1971; 123: 371–377.
   PubMed Web of Science ®Google Scholar
• Odds FC. Chronic mucocutaneous candidiosis. In: Candida and Candidosis. Baltimore, MD: University Park Press, 1988: 104–110.
   Google Scholar
• Calderone RA, ed. Candida and Candidiasis. Washington, DC: ASM Press; 2002.
   Google Scholar
• Hauman CH, Thompson IC), Theunissen F, Wolfaart P. Oral Carriage of Candida in healthy and HIV-seropositive persons. Oral Surg Oral Med Oral Pathol 1993; 76: 570–572.
   PubMedGoogle Scholar
• Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci 1988; 544: 547–557.
   PubMedGoogle Scholar
• Cenci E, Romani L, Vecchiarelli A, Puccetti P, Bistoni F. T cell subsets and INF-gamma production in resistance to systemic candidosis in immunized mice. J Immuno11990; 144: 4333–4339.
   Google Scholar
• Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. C1M Infect Dis 1992; 14 (suppl 1): S148–S153
   Google Scholar
• Fichtenbaum CJ, Powderly W. Refratory mucosal Candidiasis in patients with human immunodeficiency virus infection. Clin Infect Dis 1998; 26: 556–565.
   PubMed Web of Science ®Google Scholar
• Lynch ME, Sobel JD, Fidel PL, Jr. Role of antifingal drug resistance in the pathogenesis of recurrent vulvovaginal candidasis. J Med Vet Mycol 1996; 34: 337–339.
   Google Scholar
• Cenci E, Mencacci A, Spaccapelo R, et al. T helper cell type 1 (ml)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Thl development. J Infect Dis 1995; 171: 1279–1288.
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P, Bistoni F. Biological role of Th cell subsets in candidiasis. Romagnani S, ed. In: Thl and Th2 Cells in Health and Disease. Farmington, CT: Karger, 1996: 114–137.
   Google Scholar
• Kirkpatrick CH. Chronic mucocutaneous candidiasis. Eur J Clin Micro biol Infect Dis 1989; 8: 448–456.
   PubMedGoogle Scholar
• Liljemark WF, Gibbons RJ. Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect Immun 1973; 8: 846–849.
   PubMed Web of Science ®Google Scholar
• Casadevall A. Antibody immunity and invasive fungal infec-tions. Infect Immun 1995; 63: 4211–4218.
   PubMed Web of Science ®Google Scholar
• Fidel PL, Jr., Lynch ME, Sobel JD. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect Immun 1993; 6t 1990–1995.
   Google Scholar
• Fidel PL, Jr., Lynch ME, Sobel JD. Candida-specific ml-type responsiveness in mice with experimental vaginal candidiasis. Infect Immun 1993; 61 4202–4207.
   Google Scholar
• Fidel PL, Jr., Lynch ME, Sobel JD. Effects of preinduced Candida-specific systemic cell-mediated immunity on experi-mental vaginal candidiasis. Infect Immun 1994; 62: 1032–1038.
   Google Scholar
• Fidel PL, Jr., Lynch ME, Conaway DH, Tait L, Sobel JD. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect Immun 1995; 63: 547–553.
   Google Scholar
• Fidel PL, Jr., Lynch ME, Sobel JD. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun 1995; 63: 2403–2408.
   PubMed Web of Science ®Google Scholar
• Hector RF, Domer JE, Carrow EW. Immune responses to Candida albicans in genetically distinct mice. Infect Immun 1982; 38: 1020–1028.
   PubMed Web of Science ®Google Scholar
• Fidel PL, Jr., Cutright JL, Sobel JD. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections. Infect Immun 1995; 63: 4191–4194.
   Google Scholar
• Black CA, Eyers FM, Russell A, et al. Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes. J Reprod Immuno11999; 45: 1–18.
   Google Scholar
• Mulero-Marchese RD, Blank KJ, Sieck TG. Genetic basis for protection against experimental vaginal candidiasis by periph-eral immunization. J Infect Dis 1998; 178: 227–234.
   Google Scholar
• Mulero-Marchese RD, Blank KJ, Sieck TG. Strain-dependent migration of lymphocytes to the vaginal mucosa after peripheral immunization. Immunogenetics 1999; 49: 973–980.
   Google Scholar
• Kirkpatrick CH, Rich RR, Bennett JE. Chronic mucocutaneous candidiasis: Model Building in cellular immunity. Ann Intern Med 1971; 74: 955–978.
   Google Scholar
• Mathur S, Virella G, Koistinen J, et al. Humoral immunity in vaginal candidiasis. Infect Immun 1977; 15: 287–294.
   Google Scholar
• Witkin SS. Inhibition of Candida-induced lymphocyte prolifera-tion by antibody to Candida albicans. Obstet Gynecol 1986; 68: 696–699.
   PubMedGoogle Scholar
• Witkin SS, Hirsch J, Ledger WJ. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol 1986; 155: 790–795.
   Google Scholar
• Hobbs JR, Briden D, Davidson F, Kahan M, Oates JK. Immunological aspects of candidal vaginitis. Proc R Soc Med 1977; 70: 11–14.
   PubMedGoogle Scholar
• Fong IW, McCleary P, Read S. Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol 1992; 166: 887–890.
   Google Scholar
• Syverson RA, Buckley H, Gibian J, Ryan JJM. Cellular and humoral immune status in women with chronic Candida vaginitis. Am J Obstet Gynecol 1979; 134: 624–627.
   PubMed Web of Science ®Google Scholar
• Mendling W, Koldovsky U. Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. Infect Dis Obstet Gynecol 1996; 4: 225–231.
   PubMedGoogle Scholar
• Fidel PL, Jr., Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J Infect Dis 1993; 168: 1458–1465.
   Google Scholar
• Nawrot U, Grzybek-Hryncewicz K, Zielska U, Czamy A, Podwinska J. The study of cell-mediated immune response in recurrent vulvovaginal candidiasis. FEMS Immunol Med Micro-biol 2000; 29: 89–94.
   Google Scholar
• Corrigan EM, Clancy RL, Dunkley ML, Eyers FM, Beagley KW. Cellular immunity in recurrent vulvovaginal candidiasis. Clin Exp Immuno11998;111: 574–578.
   Google Scholar
• Burns DN, Tuomala R, Chang BH, et al. Vaginal colonization or infection with Candida albicans in human immunodeficiency virus-infected women during pregnancy and during postpartum period. Clin Infect Dis 1997; 24: 201–210.
   PubMedGoogle Scholar
• Duerr A, Sierra MF, Feldman J, et al. Immune compromise and prevalence of Candida vulvovaginitis in human immunodefi-ciency virus-infected women. Obstet Gynecol 1997; 90: 252–256.
   PubMed Web of Science ®Google Scholar
• Spinillo A, Michelone G, Cavanna C, et al. Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women. Genitourin Med 1994; 70: 268–272.
   PubMedGoogle Scholar
• White MH. Is vulvovaginal candidiasis an AIDS-related illness? Clin Infect Dis 1996; 22 (suppl 2): 5124–S127.
   Google Scholar
• Leigh JE, Barousse M, Swoboda RK, et al. Candida-specific systemic cell-mediated immune reactivities in HIV-infected persons with and without mucosal candidiaisis.J Infect Dis 2001; 183: 277–285.
   PubMed Web of Science ®Google Scholar
• Clark RA, Blakley SA, Rice J, Brandon W. Predictors of HIV progression in women. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 43–50.
   Google Scholar
• Schuman P, Sobel JD, Ohmit S, et al. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodefriency virus infection. Clin Infect Dis 1998; 27: 1161–1167.
   PubMed Web of Science ®Google Scholar
• Rhoads JL, Wright DC, Redfield RR, Burke DS. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987; 257: 3105–3107.
   PubMed Web of Science ®Google Scholar
• Imam N, Carpenter CO, Mayer KH, et al. Hierarchical pattern of mucosal Candida infections in HIV- seropositive women. Amer J Med 1990; 89: 142–146.
   PubMed Web of Science ®Google Scholar
• Parr MB, Parr EL. Antigen recognition in the female reproductive tract: 1. Uptake of intraluminal protein tracers in the mouse vagina. J Reprod Immunol 1990; 17: 101–114.
   Google Scholar
• Parr MB, Kepple L, Parr EL. Antigen recognition in the female reproductive tract. II. Endocytosis of horseradish peroxidase by langerhans cells in murine vaginal epithelium. Biol Reprod 1991; 45: 261–265.
   Google Scholar
• Itohara S, Farr AG, Lafaille JJ, etal. Homing of a gamma/delta thymocyte subset with homogenous T-cell receptors to mucosal epithelia. Nature 1990; 343: 754–757.
   PubMed Web of Science ®Google Scholar
• Nandi D, Allison JP. Phenotypic analysis and gamma/delta-T cell receptor repertoire of murine T cells associated with the vaginal epithelium. J Immunol 1991; 147: 1773–1778.
   PubMedGoogle Scholar
• Fidel PL, Jr., Wolf NA, KuKuruga MA. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect Immun 1996; 64: 3793–3799.
   PubMed Web of Science ®Google Scholar
• Rakasz E, Hagen M, Sandor M, Lynch RG. yO_T cells of the murine vagina: T cell response in vivo in the absence of the expression of CD2 and CD28 molecules. Int Immunol 1997; 9: 161–167.
   Google Scholar
• Rakasz E, Sandor M, Hagen M, Lynch RG. Activation features of intraepithelial y6 T-cells of the murine vagina. Immunol Lett 1996; 54: 129–134.
   Google Scholar
• Wormley Jr FL, Scott M, Luo W, et al. Evidence for a unique expression of CD4 on murine vaginal CD4± cells. Immunology 2000; 100: 300–308.
   Google Scholar
• White HD, Crassi KM, Givan AL, et al. CD3+ CD8+ CTL activity within the human female reproductive tract: Influence of stage of the menstrual cycle and menopause. J Immunol 1997; 158: 3017–3027.
   PubMed Web of Science ®Google Scholar
• Hladik F, Lentz G, Delpit E, McElroy A, McElrath MJ. Coexpression of CCR5 and IL-2 in human genital but not blood cells: Implications for the ontogeny of the CCR5+ Thl phenotype. J Immunol 1999; 163: 2306–2313.
   Google Scholar
• Johansson E-L, Rudin A, Wassen L, Holmgren J. Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 2000; 96: 272–277.
   Google Scholar
• Fidel PL, Jr., Wormley FL, Jr., Chaiban J, Chesson RR, Lounev V. Analysis of the CD4 protein on human vaginal CD4 ± T cells. Am J Reprod Immunol 2001; 45: 200–204.
   Google Scholar
• Cantoma MT, Mook D, Balish E. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidasis. Infect Immun 1990; 58: 3813–3815.
   Google Scholar
• Fidel PL, Jr., Luo W, Steele C, et al. Analysis of vaginal cell populations during experimental vaginal candidiasis. Infect Immun 1999; 67: 3135–3140.
   PubMed Web of Science ®Google Scholar
• Fidel PL, Jr., Luo W, Chabain J, Wolf NA, Van Buren E. Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery. Infect Immun 1997; 65: 3939–3943.
   Google Scholar
• Hawkins RA, Rank RG, Kelly KA. Expression of mucosal homing receptor a4137 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo. Infect Immun 2000; 68: 5587–5594.
   Google Scholar
• Hawkins RH, Kelly KA, Rank RG. Expression of a mucosal-associated integrin may influence the trafficking of a protective MoPn-specific CD4 clone to the genital tract during chlamydial genital infection. In: Stephens R, ed. Proceedings of the Ninth International Symposium on Human Chlamydial infection, Napa Valley, CA. San Francisco, CA: International Chlamydia Symposium, 1998; 395–398.
   Google Scholar
• Kelly KA, Rank RG. Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun 1997; 65: 5198–5208.
   PubMed Web of Science ®Google Scholar
• Parr MB, Parr EL. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo-depletion of T lymphocytes. J Virol 1998; 72: 2677–2685.
   PubMedGoogle Scholar
• Parr MB, Pan EL. Protective immunity against HSV-2 in the mouse vagina. J Reprod Immunol 1997; 36: 77–92.
   PubMed Web of Science ®Google Scholar
• Kelly KA, Gray HL, Walker JC, et aL Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida albicans vaginal infection. Infect Immun 2001; 69: 3451–3454.
   Google Scholar
• Jones-Carson J, Vazquez-Torres A, van der Heyde HC, et al. y cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nature Med 1995; 6: 552–557.
   Google Scholar
• Wormley Jr FL, Steele C, Wozniak K, et al. Resistance of TCR 6-chain knock-out mice to experimental Candida vaginitis. Infect Immun 2001; 69: 7162–7164.
   Google Scholar
• Saavedra M, Taylor B, Lukacs NW, Fidel PL, Jr. Local production of chemoldnes during experimental vaginal candi-diasis. Infect Immun 1999; 67: 5820–5829.
   Google Scholar
• Taylor BN, Saavedra M, Fidel PL, Jr. Local Th1/Th2 cytokine production during experimental vaginal candidiasis. Med Mycol 2000; 38: 419–431.
   PubMedGoogle Scholar
• Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998; 19: 568–574.
   Google Scholar
• Little CH, Georgiou GM, Marceglia A, etal. Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginalcandidiasis. Infect Immun 2000; 68:3840–3847.
   PubMed Web of Science ®Google Scholar
• Salmi M, Jalkanen S. How do lymphocytes know where to go: Current concepts and enigmas of lymphocyte homing. Adv Immunol 1997; 64: 139–218.
   PubMed Web of Science ®Google Scholar
• Hamann A, Andrew DP, Jablonski-Westrich D, Holzmann B, Butcher EC. Role of a_-integrins in lymphocytes homing to mucosal tissues in vivo. J Immunol 1994; 152: 3282–3293.
   Google Scholar
• Cepek KL, Shaw SK, Parker CM, et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 1994; 372: 190–193.
   PubMed Web of Science ®Google Scholar
• Wormley FL, Jr., Chaiban J, Fidel PL, Jr. Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis. Infect Immun 2001; 69: 5072–5079.
   Google Scholar
• De Bemardis F, Santoni G, Boccanera M, et al. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun 2000; 68: 3297–3304.
   PubMed Web of Science ®Google Scholar
• Romani L, Mocci S, Bietta C, et al. Thl and Th2 cytokine secretion patterns in murine candidiasis: Association of Thl responses with acquired resistance. Infect Immun 1991; 59: 4647–4654.
   PubMed Web of Science ®Google Scholar
• Romani L, Mencacci A, Cenci E, et al. CD4+ subset expression in murine candidiasis. J Immuno11993; 150: 925–931.
   PubMed Web of Science ®Google Scholar
• Fidel PL, Jr., Ginsburg KA, Cutright JL, et al. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: Evidence for vaginal Thl-type responses following intravaginal challenge with Candida antigen. J Infect Dis 1997; 176: 728–739.
   PubMed Web of Science ®Google Scholar
• Fidel PL, Jr., Barousse M, Espinosa T, Chesson RR, Dunlap K. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle. Med Mycol 2002; 40 (in press).
   Google Scholar
• Regulez P, Garcia Fernandez JF, Moragues MD, et al. Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis. Gynecol Obstet Invest 1994; 37: 110–114.
   PubMed Web of Science ®Google Scholar
• Witkin SS, Jeremias J, Ledger WJ. Vaginal eosinophils and IgEantibodies to Candida albicans in women with recurrent vaginitis. J Med Vet Mycol 1989; 27: 57–58.
   Google Scholar
• Witkin SS, Jeremias J, Ledger WJ. A localized vaginal allergic response in women with recurrent vaginitis. J Allergy Clin Immunol 1988; 81: 412–416.
   Google Scholar
• Parr MB, Parr EL. Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol Reprod 1991; 44:491–498.
   PubMed Web of Science ®Google Scholar
• Kutteh WH, Moldoveanu Z, Mestecky J. Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Human Retro 1998; 14 (suppl 1): 51–55.
   Google Scholar
• Wira CR, Richardson J, Prabhala R. Endocrine regulation of mucosal immunity: effect of sex hormones and cytokines on the afferent and efferent arms of the immune system in the female reproductive tract. In: Ogra PL, Mestecky JJ, Lamm ME, eds Handbook of Mucosal Immunity. San Diego: Academic Press, Inc., 1994: 705–718.
   Google Scholar
• Wozniak KL, Wormley FL, Jr., Fidel PL, Jr. Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect Immun 2002; (In press).
   Google Scholar
• Polonelli L, De Bemardis F, Conti S, et al. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory,yeast killer toxin-like anti-idiotypic antibodies. J Immunol 1994; 152: 3175–3182.
   PubMed Web of Science ®Google Scholar
• Polonelli L, De Bemardis F, Conti S, et al. Human natural yeast killer toxin-like andidicidal antibodies. J Immunol 1996; 156: 1880–1885.
   PubMedGoogle Scholar
• Cassone A, Boccanera M, Adriani DA, Santoni G, De Bemardis F. Rats clearing a vaginal infection by Candida albicans aquire specific, antibody-mediated resistance to vaginal infection. Infect Immun 1995; 63: 2619–2624.
   Google Scholar
• De Bemardis F, Boccanera M, Adriana D, et al. Protective roleof antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun 1997; 65: 3399–3405.
   PubMed Web of Science ®Google Scholar
• Han Y, Morrison RP, Cutler JE. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect Immun 1998; 66: 5771–5776.
   Google Scholar
• Han Y, Riesselman MH, Cutler JE. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect Immun 2000; 68: 1649–1654.
   Google Scholar
• Black CA, Eyers FM, Russell A, et al. Acute neutropenia decreases inflammation associated with murine vaginal candi-diasis but has no effect on the course of infection. Infect Immun 1998; 66: 1273–1275.
   PubMed Web of Science ®Google Scholar
• Djeu JY, Blanchard DK. Regulation of human polymorpho-nuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J Immunol 1987; 139: 2761–2767.
   Google Scholar
• Arancia G, Molinari A, Crateri P, et al. Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans. Infect Immun 1995; 63: 280–288.
   PubMed Web of Science ®Google Scholar
• Hedges SR, Agace WW, Svanborg C. Epithelial cytokine responses and mucosal cytokine networks. Trends in Micro 1995; 3: 266–270.
   Google Scholar
• Fratti RA, Ghannoum MA, Edwards JE, Jr., Filler SG. Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect Immun 1996; 64: 4714–4718.
   Google Scholar
• Steele C, Ozenci H, Luo W, Scott M, Fidel PL, Jr. Growth inhibition of Candida albicans by vaginal cells from naive mice. Med Mycol 1999; 37: 251–260.
   PubMed Web of Science ®Google Scholar
• Steele C, Ratterree M, Fidel PL, Jr. Differential susceptibility to experimental vaginal candidiasis in macaques. J Infect Dis 1999; 180: 802–810.
   Google Scholar
• Fidel PL, Jr., Cutright JL, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis. Infect Immun 2000; 68: 651–657.
   PubMed Web of Science ®Google Scholar
• Barousse MM, Steele C, Dunlap K, et al. Growth inhibition of Candida albicans by human vaginal epithelial cells. J Infect Dis 2001; 184: 1489–1493.
   Google Scholar
• Samaranayake LP. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol 1992; 73: 171–180.
   PubMedGoogle Scholar
• Reichart PA, Samaranayake LP, Philipsen HP. Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Diseases 2000; 6: 85–91.
   Google Scholar
• Greenspan JS, Barr CE, Sciubba JJ, Winkler JR. Oral manifestations of HIV infection: definitions, diagnostic criteria and principles of therapy. Oral Surg Oral Med Oral Path 1992; 73: 142–144.
   PubMedGoogle Scholar
• Schuman P, Ohmit S, Sobel J.D., Mayer KH, Greene V, Rompalo A, and Klein RS. Oral lesions among women living with or at risk for HIV infection. Amer J Med. 1998; 104: 559–563.
   Google Scholar
• Palacio H, Hilton JF, Canchola AJ, Greenspan D. Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 338–342.
   PubMedGoogle Scholar
• Galai N, Park LP, Wesch J, et al. Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 451–458.
   PubMedGoogle Scholar
• Greenspan D, Komaroff E, Redford M, et al. Oral mucosal lesions and HIV viral load in the Women's interagency HIV study (WIHS). J Acquir Immune Defic Syndr 2000; 25: 44–50.
   PubMed Web of Science ®Google Scholar
• Hickman P, Leigh JE, Fidel PL, Jr., Luftig RB. Oropharyngeal candidiasis in HIV patients may influence the selection of HIV-1 protease variants. Virus Res 2002; (In press).
   Google Scholar
• Quinti I, Palma C, Guerra EC, et al. Proliferative and cytotxic responses to mannoproteins of Candida albicans by peripheral blood lymphocyes of HIV-infected subjects. Clin Exp Immunol 1991; 85: 1–8.
   Google Scholar
• Nagai Y, Takeshita N, Saku T. Histopathologic and ultra-structural studies of oral mucosa with Candida infection. J Oral Pathol Med 1992; 21: 171–175.
   Google Scholar
• Samaranayake YH, Samaranayake LP. Experimental oral candidiasis in animal models. Clin Microbiol Rev 2001; 14: 398–429.
   PubMed Web of Science ®Google Scholar
• Balish E, Balish MJ, Salkowski CA, Lee KW, Bartizal KF. Colonization of congenitally athymic, gnotobiotic mice by Candida albicans. App Environ Micro 1984; 47: 647–652.
   PubMedGoogle Scholar
• Balish E, Filutowicz H, Oberley TD. Correlates of cell-mediated immunity in Candida albicans- colonized gnotobiotic mice. Infect Immun 1990; 58: 107–113.
   Google Scholar
• Cantoma MT, Balish E. Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis 1991; 164: 936–943.
   Google Scholar
• Balish E, Jensen J, Warner T, Brekker J, Leonard B. Mucosal and disseminated candidiasis in gnotobiotic SCID mice. J Med Vet Mycol 1993; 31: 143–153.
   PubMedGoogle Scholar
• Allen CM, Saffer A, Meister RK, Beck FM, Bradway S. Comparison of a lesion-inducing isolate and a non-lesional isolate of Candida albicans in an immunosuppressed rat model of oral candidiasis. J Oral Pathol Med 1994; 23: 133–139.
   Google Scholar
• Chakir J, Cote L, Coulombe C, Deslauriers N. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol Immunol 1994; 9: 88–94.
   PubMedGoogle Scholar
• Seymour GJ, Taubman MA, Eastcott JW, Gemmell E, Smith DJ. CD29 expression on CD4+ gingival lymphocytes supports migration of activated memory T lymphocytes to diseased periodontal tissue. Oral Microbiol Immunol 1997; 12: 129–134.
   Google Scholar
• Gomez RS, Alencar de Souza PE, Eustaquio da Costa J, Araujo NS. CD30+ lymphocytes in chronic gingivitis from HIV-positive patients: A pilot study. J Periodontol 1997; 68: 881–883.
   Google Scholar
• Deslauriers N, Cote L, Montplaisir S, De Repentigny L. Oral carriage of Candida albicans in murine AIDS. Infect Immun 1997; 65: 661–667.
   PubMedGoogle Scholar
• Beno DWA, Mathews HL. Growth inhibition of Candida albicans by interleukin-2-induced lymph node cells. Cell Immunol 1990; 128: 89–100.
   PubMedGoogle Scholar
• Beno DWA, Stover AG, Mathews HL. Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J Immunol 1995; 154 : 5273–5281.
   Google Scholar
• Kunkl A, Mortara L, Valle MT, et al. Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons. J Infect Dis 1998; 178: 488–496.
   Google Scholar
• Elahi S, Pang G, Clancy R, Ashman RB. Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect Immun 2000; 68: 5771–5777.
   Google Scholar
• Farah CS, Elahi S, Drysdale K, et al. Primary role for CD4± T lymphocytes in recovery from oropharyngealcandidiasis. Infect Immun 2002; 70: 724–731.
   PubMed Web of Science ®Google Scholar
• Farah CS, Hong S, Wanasaengsakul S, et al. Irradiation-induced oral candidiasis in an experimental murine model. Oral Microbiol Immunol 2001; 16: 358–363.
   Google Scholar
• Leigh JE, Steele C, Wormley Jr FL, et al. Thl/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: A pilot study in HIV-positive individuals with oropharyngeal candidiasis. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 373–380.
   Google Scholar
• Leigh JE, Steele C, Wormley FL, Jr., Fidel PL, Jr. Salivary cytokine profiles in the immunocompetent individual with Candida-associated denture stomatitis. Oral Microbiol Immu-nol 2002; (In press).
   Google Scholar
• Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998; 9: 248–266.
   PubMedGoogle Scholar
• Yamazaki K, Nakajima T, Hara K. Immunohistological analysis of T cell functional subsets in chronic inflammatory periodontal disease. Clin Exp Immunol 1995; 99: 384–391.
   Google Scholar
• Vastardis S, Wozniak K, Yukna RA, Fidel PL, Jr., Leigh JE. Cytokines in the saliva of HIV-positive individuals with and without periodontal disease. Oral Microbiol Immunol 2002; (submitted).
   Google Scholar
• Odden K, Schenck K, Hurlen B. High numbers of T cells in gingiva from patients with human immunodeficiency virus (HIV) infection. J Oral Pathol Med 1995; 24: 413–419.
   Google Scholar
• Steidley KB, Thompson SH, McQuade MJ, et al. A comparison of T4: T8 lymphocyte ratio in the periodontal lesion of healthy and HIV-positive patients. J Periodonto11992; 63: 753–756.
   PubMed Web of Science ®Google Scholar
• Colon M, Toledo N, Valiente CL, et al. Anti-fungal and cytokine producing activities of CD8+ T lymphocytes from HIV-1 infected individuals. AIDS Research 1998; 90: 21–26.
   Google Scholar
• Levy JA, Hsueh F, Blackboum DJ, Wara D, Weintrub PS. CD8 cell noncytotoxic antiviral activity in human immunode-ficiency virus-infected and -uninfected children. J Infect Dis 1998; 177: 470–472.
   Google Scholar
• Stranford SA, Skumick J, Louria D, et al. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proc Natl Acad Sci USA 1999; 96: 1030–1035.
   Google Scholar
• Romagnoli P, Pimpinelli N, Mori M, et al. Immunocompetent cells in oral candidiasis of HIV-infected patients: an immuno-histochemical and electron microscopical study. Oral Diseases 1997; 3: 99–105.
   Google Scholar
• Williams DW, Potts AJC, Wilson MJ, Matthews JB, Lewis MAO. Characterisation of the inflammatory cell infiltrate in chronic hyperplastic candidosis of the oral mucosa. J Oral Pathol Med 1997; 26: 83–89.
   Google Scholar
• Coogan MM, Sweet SP, Challacombe SJ. Immunoglobulin A (IgA), IgAl, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun 1994; 62: 892–896.
   Google Scholar
• Challacombe SJ, Sweet SP. Salivary and mucosal immune responses to HIV and its co-pathogens. Oral Diseases 1997; 3 (suppl 1): S79–S84
   Google Scholar
• Sweet SP, Challacombe SJ, Naglik JR. Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection. Adv Exp Med Biol 1995; 371(B): 1031–1034.
   Google Scholar
• Millon L, Drobacheff C, Piarroux R, et al. Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients. J Acquir Immune Defic Syndr 2001; 26: 137–144.
   Google Scholar
• Wray D, Felix DH, Cumming CG. Alteration of humoral responses to Candida in HIV infection. Br Dent J 1990; 168: 326–329.
   Google Scholar
• Wozniak KL, Leigh JE, Hager S, Swoboda RK, Fidel PL, Jr. A Comprehensive study of Candida-specific antibodies in saliva of HIV-infected persons with oropharyngeal candidiasis. J Infect Dis 2002; 185: 1269–1276.
   Google Scholar
• Farah CS, Elahi S, Pang G, et al. T Cells Augment Monocyte and Neutrophil Function in Host Resistance against Orophar-yngeal Candidiasis. Infect Immun 2001; 69: 6110–6118.
   PubMed Web of Science ®Google Scholar
• Steele C, Leigh JE, Swoboda RK, Fidel PL, Jr. Growth inhibition of Candida by human oral epithelial cells. J Infect Dis 2000; 182: 1479–1485.
   Google Scholar
• Steele C, Fidel PL, Jr. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 2002; 170: 577–583.
   Google Scholar
• Dongari-Bagtzoglou A, Wen K, Lamster IB. Candida albicans triggers interleukin-6 and interleukin-8 responses by oral fibroblasts in vitro. Oral Microbiol Immuno11999; 14: 364–370.
   Google Scholar
• Weinberg A, Krisanaprakomkit S, Dale BA. Epithelial antimicrobial peptides: review and significance for oral applications. Grit Rev in Oral Bio Med 1998; 9: 399–414.
   Google Scholar
• Xu T, Levitz SM, Diamond RD, Oppenheim FG. Anticandidal activity of major human salivary histatins. Infect Immun 1991; 59: 2549–2554.
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P, Gabrielsen TO, Dale I, et al. The leucocyte protein Li (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Bio 1995; 371 201–206.
   Google Scholar
• Jorge AOCTMAG, De Alemida OP, Scully C. Oral candidiasis established in the sialoadenectomised rat. J Oral Pathol Med 1993; 22: 52–56.
   Google Scholar
• Meitner SW, Bowen WH, Haidaris CG. Oral and esophageal Candida albicans infection in hyposalivatory rats. Infect Immun 1990; 58: 2228–2236.
   PubMed Web of Science ®Google Scholar
• Lin AL, Shi Q, Johnson DA, et al. Further characterization of human salivary anticandidal activities in a human immunode-ficiency virue-positive cohort by use of microarrays. Clin Diagn Lab Immunol 1999; 6: 851–855.
   Google Scholar
• Oppenheim FG, Xu T, McMillian FM, et al. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 1988; 263: 7472–7477.
   Google Scholar